Amwise Diagnostic
Healthcare Services · Taiwan · 11-50 Employees
View Company Info for Free
Overview
Headquarters
40號 敦化南路二段 3樓, 台北市 大安區, 106, TaiwanPhone Number
+44 800271271Website
www.amwisediagnostics.comRevenue
<$5 MillionIndustry
About Amwise Diagnostic
Amwise Diagnostic Org Chart
Is Amwise Diagnostic your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Amwise Diagnostic recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Amwise Diagnostic
Product Launch: Get notified when Amwise Diagnostic launches new products
Check out if Amwise Diagnostic is spiking on competitors!
Funding: Get notified immidiatlly once Amwise Diagnostic has new funding data
Amwise Diagnostic, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Amwise Diagnostic had a recent Job posting/layoffs
Check if Amwise Diagnostic has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at Amwise Diagnostic
Find 3 more new buyers
Company Profile Activity
Activity Insights
Amwise Diagnostic is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
Amwise Diagnostic is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about Amwise Diagnostic.
Amwise Diagnostic Tech Stack
A closer look at the technologies used by Amwise Diagnostic
Top Healthcare Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Amwise Diagnostic
RecurIndex specializes in genetic testing for breast cancer recurrence risk, particularly tailored for Asian patients. Their unique testing combines genetic and clinical data to provide a comprehensive analysis of the risk of local recurrence and distant metastasis. The service is designed for early-stage breast cancer patients considering postoper... Read More